Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anticancer Drugs”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableLooking for participantsNCT04484064
What this trial is testing

Optimization of the Targeted Anticancer Therapies

Who this might be right for
Cancer
Centre Hospitalier Universitaire Vaudois 500
Not applicableStudy completedNCT03952312
What this trial is testing

Oncotool for Cancer Medications

Who this might be right for
CancerCancer, Treatment-RelatedMedication Adherence+2 more
Northwestern University 83
Not applicableUnknownNCT02733965
What this trial is testing

Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events

Who this might be right for
Oral Anticancer Therapy.
Assistance Publique Hopitaux De Marseille 190
Not applicableUnknownNCT04613765
What this trial is testing

A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting

Who this might be right for
AdultsHematological MalignancyOral Antineoplastic Agents
Jules Bordet Institute 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548127
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Who this might be right for
Breast Cancer
Pfizer 37
Early research (Phase 1)Study completedNCT01894256
What this trial is testing

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Who this might be right for
Solid Tumours
AstraZeneca 56
Not applicableStudy completedNCT02833246
What this trial is testing

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Who this might be right for
SarcomaLungSolid Tumor Gastrointestinal
Memorial Sloan Kettering Cancer Center 28
Early research (Phase 1)Study completedNCT01921140
What this trial is testing

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05573555
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Who this might be right for
Breast Cancer
Pfizer 20
Not applicableLooking for participantsNCT03296150
What this trial is testing

ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE

Who this might be right for
CancerOral Anticancer Drugs
Hospices Civils de Lyon 139
Not applicableStudy completedNCT05069662
What this trial is testing

Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients

Who this might be right for
Cancer
Hospices Civils de Lyon 120
Not applicableStudy completedNCT04626830
What this trial is testing

Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management

Who this might be right for
CancerAdherence to Medication RegimeSymptom Management
Baskent University 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT06125522
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Who this might be right for
Breast Cancer
Pfizer 11
Early research (Phase 1)Study completedNCT02138526
What this trial is testing

Pazopanib Tolerability When Given With Food

Who this might be right for
Cancer
Radboud University Medical Center 78
Early research (Phase 1)Study completedNCT01900028
What this trial is testing

To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 85
Early research (Phase 1)Study completedNCT02908750
What this trial is testing

Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 24
Early research (Phase 1)Study completedNCT01929603
What this trial is testing

Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 32
Not applicableLooking for participantsNCT06566560
What this trial is testing

The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs

Who this might be right for
CancerOncologyPharmacy+1 more
Radboud University Medical Center 2,500
Not applicableLooking for participantsNCT06726889
What this trial is testing

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
European Institute of Oncology 104
Not applicableLooking for participantsNCT06317389
What this trial is testing

PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments

Who this might be right for
CancerOncologyOncoral Program
Hospices Civils de Lyon 3,000
Load More Results